Vigilance for veterinary medicinal products: Declarations of suspected adverse reactions in the year 2007

被引：7
|
作者：
Muentener, C. R. [1 ,2 ]
Bruckner, L. [3 ]
Stuerer, A. [4 ]
Althaus, F. R. [1 ]
Schneider, A. [2 ]
机构：
[1] Univ Zurich, Inst Vet Pharmakol & Toxikol, CH-8057 Zurich, Switzerland
[2] Schweizer Heilmittelinst, Bern, Switzerland
[3] IVI, Mittelhausern, Germany
[4] STIZ, Zurich, Switzerland
来源：
SCHWEIZER ARCHIV FUR TIERHEILKUNDE | 2009年 / 151卷 / 01期
关键词：
pharmacovigilance; vaccinovigilance; reconversion; residues; Delvo test; DRUG-REACTIONS; VACCINES; AMITRAZ;
D O I：
10.1024/0036-7281.151.1.12
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
163 reports of suspected adverse reactions were received in the year 2007: 111 for veterinary medicinal (VMPs) and 52 for immunologic products. Half of the reported reactions for VMPs concerned either an antiparasitic drug (26%) or an antibiotic (24%). Reconversions (use in another target species or for another indication as registered) made the third most frequently mentioned group with I I reports. For immunologicals, half of the declarations were related to an adverse reaction in dogs, the most frequently reported reaction in companion animals being allergies. Moreover, 272 enquiries were received by the Swiss Toxicological Information Center in Zurich. Most of these were related to dogs (73%) and the number of enquiries regarding VMPs correlated positively with the most frequently used therapeutic classes like anti-parasitics (47%) and anti-inflammatory drugs (23%). The complexity of proscessing reports regarding the detection of residues in milk after prescribed withdrawal times is discussed in detail. In conclusion, the year 2007 is seen as a consolidation of the established system with a tendency towards increase in the number of complex cases.
引用
收藏
页码：12 / 20
页数：9
相关论文
共 17 条
  • [11] Declarations of suspected adverse reactions due to veterinary drugs and vaccines in 2006
    Muentener, C. R.
    Bruckner, L.
    Gassner, B.
    Stuerer, A.
    Demuth, D. C.
    Althaus, F. R.
    Zwahlen, R.
    SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2007, 149 (10): : 439 - 448
  • [12] Vaccinovigilance: Reported adverse reactions of immunological veterinary medicinal products in 2018
    Rogger, P.
    Herrmann, N.
    Ottiger, H. P.
    SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2019, 161 (05): : 299 - 306
  • [13] Declaration of suspected adverse reactions for veterinary drugs and vaccines in 2005
    Muentener, C. R.
    Bruckner, L.
    Gassner, B.
    Demuth, D. C.
    Althaus, F. R.
    Zwahlen, R.
    SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2007, 149 (02): : 57 - 63
  • [14] Adverse Reactions to Ginkgo biloba Medicinal Products Released in European Countries
    Ammendolia, Ilaria
    Attard, Everaldo
    Mannucci, Carmen
    Esposito, Emanuela
    Calapai, Gioacchino
    Curro, Mariaconcetta
    Midiri, Paola
    Attard, Tamara
    Cardia, Luigi
    Calapai, Fabrizio
    PHYTOTHERAPY RESEARCH, 2025,
  • [15] Suspected adverse reactions to veterinary drugs reported in South Africa (January 1998-February 2001)
    Gehring, R
    JOURNAL OF THE SOUTH AFRICAN VETERINARY ASSOCIATION, 2001, 72 (03) : 120 - 126
  • [16] Spontaneously reported fatal suspected adverse drug reactions:: a 10-year survey from Sweden
    Wester, Karin
    Jonsson, Anna
    Spigset, Olav
    Hagg, Staffan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (02) : 173 - 180
  • [17] Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study
    Skvrce, Nikica Miroevic
    Sarinic, Viola Macolic
    Mucalo, Iva
    Krnic, Darko
    Bozina, Nada
    Tomic, Sinisa
    CROATIAN MEDICAL JOURNAL, 2011, 52 (05) : 604 - 614
12